PharmaCan Capital

PharmaCan is a private equity firm in the business of investing in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations (“MMPR”). PharmaCan has a diversified portfolio of investments including investments in 7 of the 26 companies licensed by Heath Canada to produce medical marijuana. PharmaCan's first investee company, The Peace Naturals Project (“Peace Naturals”), was the first producer to be granted a license by Health Canada for the commercial production and distribution of medical cannabis under the MMPR. PharmaCan has a significant minority interest in Whistler Medical Marijuana Company (“WMMC”), Canada’s first certified organic producer of medical marijuana. Both Peace Naturals and WMMC are licensed to produce and sell medical cannabis. PharmaCan also owns 100% of In The Zone Produce Ltd., a licensed producer based in British Columbia's Okanagan Valley. PharmaCan has minority investments in two additional companies licensed to produce medical marijuana under the MMPR, ABcann and Hydropothecary. PharmaCan’s remaining investments are in companies currently in the license application stage.
Type
Public
HQ
Toronto, CA
Founded
2012
Size (employees)
4 (est)
PharmaCan Capital was founded in 2012 and is headquartered in Toronto, CA

Key People at PharmaCan Capital

Paul Rosen

Paul Rosen

CEO

PharmaCan Capital Office Locations

PharmaCan Capital has office in Toronto
Toronto, CA

PharmaCan Capital Metrics

PharmaCan Capital Summary

Market capitalization

$323.1 m

Closing share price

$2.7
PharmaCan Capital's current market capitalization is $323.1 m.

PharmaCan Capital Market Value History

PharmaCan Capital Company Life

You may also be interested in